TSE:4519Pharmaceuticals
Why Chugai Pharmaceutical (TSE:4519) Is Up 14.6% After Japan’s 2025 Flu Outbreak Drives Vaccine Demand And What’s Next
Earlier in 2025, Japan experienced a major influenza outbreak, which led to heightened demand for flu vaccines and increased government collaboration with pharmaceutical companies.
This surge in demand placed companies like Chugai Pharmaceutical in a central role, highlighting the importance of rapid pharmaceutical innovation and supply chain responsiveness during public health emergencies.
We'll explore how the elevated demand from the influenza outbreak could reshape Chugai...